Product Information
IBUPROFEN 800 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0573 per EA under NDC 69367039605. Its NADAC has been published 118 times since Jul 3, 2024.
FDA first approved this application on Nov 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367039605
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA202413FDA Approved
11/23/2016
TE Code
AB
On Market Since
5/23/2024
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 800 MG TABLET has been published 118 times since Jul 3, 2024, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0573 per EA |
|---|---|
| All-time high | $0.0651 (Sep 11, 2024) |
| All-time low | $0.0511 (Nov 20, 2024) |
| 52-week high | $0.0587 |
| 52-week low | $0.0549 |
| Median price | $0.0576 |
| Average price | $0.0585 |
| Largest weekly change | +20.0% (Aug 21, 2024) |
| Weeks tracked | 118 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Westminster Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IBUPROFEN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.0573 per EA (NDC 69367039605), effective Sep 30, 2026.
How has the price of IBUPROFEN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has declined 10.9%. It has been tracked across 118 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?
Since Jul 3, 2024, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0511 (Nov 20, 2024) to a high of $0.0651 (Sep 11, 2024), with a median of $0.0576 per EA.
Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 800 MG TABLET, is $0.0567 per EA — about 1% below IBUPROFEN 800 MG TABLET.
Who manufactures IBUPROFEN 800 MG TABLET?
IBUPROFEN 800 MG TABLET (NDC 69367039605) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.